Created at	Source	Raw Value	Validated value
Nov. 26, 2021, 10:30 p.m.	oms	To investigate the clinical efficacy of XAR-XAP treatment in reducing the duration and severity of illness compared to placeboTimepoint: Day 0; Day 15; Day 30; Day 60; Day 90	To investigate the clinical efficacy of XAR-XAP treatment in reducing the duration and severity of illness compared to placeboTimepoint: Day 0; Day 15; Day 30; Day 60; Day 90
Nov. 13, 2021, 5:33 p.m.	oms	N/A	N/A
Sept. 8, 2021, 1:30 a.m.	oms	To investigate the clinical efficacy of XAR-XAP treatment in reducing the duration and severity of illness compared to placeboTimepoint: Day 0; Day 15; Day 30; Day 60; Day 90	To investigate the clinical efficacy of XAR-XAP treatment in reducing the duration and severity of illness compared to placeboTimepoint: Day 0; Day 15; Day 30; Day 60; Day 90